In this review:
Predictors of progression in Barrett’s oesophagus
Acute MI in patients with Barrett’s oesophagus
Oral budesonide suspension for oesophagitis
Drug levels and antibodies to infliximab in CD patients
Anti-TNF withdrawal and relapse in IBD
Comparative effectiveness and safety of anti-TNFs in CD
Azathioprine/6-mercaptopurine and infliximab levels
Leadership training to improve ADR
Quality indicator to predict adenoma miss rate
NZ FIT-based CRC screening pilot
Predictors of CD relapse after anti-TNF withdrawal
Drug levels and antibodies to infliximab in CD patients
Population pharmacokinetic study in IBD
Dose optimisation of infliximab
Intolerance of uncertainty and QoL in UC
Please login below to download this issue (PDF)